Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Diana C Diaz Cartagena

Diana C Diaz Cartagena

University of Puerto Rico, Puerto Rico

Title: Impedimetric Detection of Telomerase Activity in Cancer Cells

Biography

Biography: Diana C Diaz Cartagena

Abstract

Over the last decade, an increasing number of researchers have focused on developing rapid techniques based on biosensor technology for the detection of various human health related conditions. The use of this technology helps to detect early signs of the disease, such as cancer, in a short period of time with high efficiency. The number of cases diagnosed with this condition is increasing throughout the years due to the unhindered growth of abnormal cells partially caused by an enzyme called telomerase. This enzyme activates and elongates telomeres at the end of the chromosomal DNA, which causes cancer cells to become immortal. Telomerase is present in the vast majority of cancer types, therefore, serves as a biomarker. In this work, we developed a DNA biosensor using self-assembled monolayer technique for detection of telomerase activity in cancer cells. Specifically, we used a robust miniature DNA gold electrode as the sensing platform for the capacitive detection of enzyme binding and DNA elongation processes by telomerase utilizing electrochemical impedance spectroscopy. We measured changes in the capacitance when the surface was exposed to telomerase and to a DNA elongation inhibitor. Also, we studied how heat-shock affects the enzyme activity using charge transfer resistance as the sensing parameter. This system provides advantages in terms of simplicity, efficiency and cost of electrode design and will have a tremendous impact on the biomedical science, filling the absence of methods that can detect telomerase in a direct readout at the point-of-care location using lab-on-a-chip technology.